Locally Advanced Cutaneous Squamous Cell Carcinoma clinical trials

Explore recruiting locally advanced cutaneous squamous cell carcinoma clinical trials.

Recruiting locally advanced cutaneous squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Cutaneous Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Open-Label, Single-Arm, Multicentre Study of Immunotherapy and non-invasive response evaluation in cutaneous squamous cell carcinoma as an organ preservation strategy: a proof of concept clinical study and translational correlates - INCEPT

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2/3, adaptive, randomized, open-label, clinical study to evaluate neoadjuvant and adjuvant V940 (mRNA-4157) in combination with pembrolizumab (MK-3475) versus standard of care, and pembrolizumab monotherapy in participants with resectable locally advanced cutaneous squamous cell carcinoma (LA cSCC) (INTerpath-007).

Italy, Czechia, Romania, Hungary, Poland, Belgium +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2 study of intratumoral administration of L19IL2/L19TNF in locally advanced Cutaneous Squamous Cell Carcinoma patients progressing on or intolerant to systemic treatment.

Italy, Germany, Greece, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630).

Germany, France, Spain, Italy, Norway, Portugal +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ETCABio - Evaluation of Skin Tests in Biotherapy Allergies

France

Therapeutic use (Phase IV) EU CTIS Study details

Locally Advanced Cutaneous Squamous Cell Carcinoma trials by city

Locally Advanced Cutaneous Squamous Cell Carcinoma clinical trials

Recruiting locally advanced cutaneous squamous cell carcinoma studies right now

L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma

Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Evaluation of Skin Tests in Biotherapy Allergies

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma